For citations:
Nedogoda S.V., Salasyuk A.S., Barykina I.N., Smirnova V.O. Pharmacoeconomic analysis of ceftazidime+avibactam (Zavicefta®) in the treatment of sepsis caused by carbapenem-resistant enterobacteria. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2019;12(2):72-84. (In Russ.) https://doi.org/10.17749/2070-4909.2019.12.2.72-84

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.